Surgery may not be the most appropriate frontline treatment for metastatic kidney cancer
Results of the phase 3 SURTIME trial comparing pretreatment with [...]
ESOU 2019: Cytoreductive nephrectomy: Current recommendations
This review paper was presented at the European Association of [...]
Pros and cons of lymph node dissection at the time of nephrectomy
The following two presentations were given at the Canadian Uro-oncology [...]
Deferred cytoreductive nephrectomy in kidney cancer fails to improve progression-free survival
Results from the phase 3 CARMENA study, published in the [...]
Highlights from video expert opinion on kidney cancer from ASCO 2018
The following video clips are useful highlights from video interviews [...]
Should the primary kidney tumour be treated in metastatic disease?
Dr Gennady Bratslavsky gave a presentation at a urology symposium [...]
CARMENA trial results show that many people with advanced kidney cancer do not need surgery
The results from CARMENA, a randomised phase III clinical trial [...]
Personalised approach to the management of kidney cancer
This article summarises a presentation by Dr Ulka Vaishampayanon at [...]
The role of cytoreductive nephrectomy in elderly patients with metastatic kidney cancer
The role of cytoreductive nephrectomy for metastatic renal cell cancer [...]
Cytoreductive nephrectomy may improve survival in papillary kidney cancer
A recent study presented at the 2018 Genitourinary Cancer Symposium [...]
